LncRNA SNHG5はPI3K/AKT経路によって胃がんにおけるmiR-92a-3p/BTG2軸を通じた細胞増殖と移動を調節する
Qi-Qi Mao1, Mei-Lin Zhang2, Liang Zhong3
1Department of Gastroenterology, Huashan Hospital, Fudan University, Shanghai 201907, China.
World journal of gastrointestinal oncology
|August 21, 2025
まとめ
長い非コーディングRNASNHG5は,miR-92a-3pとBTG2を調節することによって,胃がんの進行を抑制する. この研究は,SNHG5を胃がん治療の潜在的な標的として示しています.
科学分野:
- 腫瘍学
- 分子生物学
- 遺伝子規制
背景:
- 胃がん (GC) は,高い死亡率で重要な世界的な健康問題です.
- GCの進行に伴う分子メカニズムを理解することは,効果的な治療法の開発に不可欠です.
研究 の 目的:
- 胃がんにおける長い非コーディングRNA SNHG5 (小核RNA宿主遺伝子5) の機能的役割を調査する.
- GC進行における SNHG5,miR-92a-3p,BTG2の調節関係を解明する.
主な方法:
- SNHG5,miR-92a-3p,BTG2発現をGC組織で評価するための定量的逆転写PCRとウェスタンブラット.
- SNHG5,miR-92a-3p,BTG2との相互作用を確認するための二重ルシフェラーゼアッセイ
- SNHG5 と miR-92a-3p がGC細胞の増殖,移動,および腫瘍の成長に与える影響を評価するためのインビトロ (細胞系) とインビボ (異種移植マウスモデル) の実験.
主要な成果:
- SNHG5とBTG2はダウン調節され,miR-92a-3pはGC組織でアップ調節された.
- SNHG5の過剰表現またはmiR-92a-3pのノックダウンにより,GC細胞の増殖と移動が抑制され,BTG2の発現が増加し,PI3K/ AKT経路が抑制されました.
- in vivo試験では,SNHG5の過剰発現やmiR-92a-3pの抑制により,腫瘍の成長が低下することが示された.
結論:
- LncRNA SNHG5は胃がんの腫瘍抑制剤として作用する.
- SNHG5は,miR-92a-3p/ BTG2軸を通じたPI3K/ AKT経路を調節することによって,GC細胞の成長と移動を抑制する.
- SNHG5は胃がんの潜在的治療標的である.
関連する概念動画
lncRNA - Long Non-coding RNAs
8.9K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
8.9K
Abnormal Proliferation
4.6K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.6K
MicroRNAs
3.1K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.1K
mTOR Signaling and Cancer Progression
3.9K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.9K
The Retinoblastoma Gene
4.2K
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
4.2K
Mitogens and the Cell Cycle
6.6K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.6K


